Japanese encephalitis: Perspectives and new developments

Future Neurology

Volumn 3, Issue 5, 2008, Pages 515-521

  Saxena, Shailendra K ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; LIVE VACCINE; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS VACCINE;

ANTIBODY DETECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONVALESCENCE; CULEX TRITAENIORHYNCUS; DIFFERENTIAL DIAGNOSIS; DISEASE CARRIER; EDITORIAL; EPIDEMIC ENCEPHALITIS; GENE FUNCTION; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; JAPANESE ENCEPHALITIS VIRUS; LABORATORY DIAGNOSIS; NONHUMAN; PLACENTAL TRANSFER; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; STAGING; SYMPTOMATOLOGY; VACCINATION; VIRUS DETECTION; VIRUS ENTRY; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 55649114603     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/14796708.3.5.515     Document Type: Editorial

References (34)

1. Diagana M, Preux PM, Dumas M: Japanese encephalitis revisited. J. Neurol. Sci. 262, 165-170 (2007).
2. Ferguson M, Kurane I, Wimalaratne O et al.: WHO informal consultation group. WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006. Vaccine 25, 5233-5243 (2007).
3. Halstead SB, Jacobson J: Japanese encephalitis: Adv. Virus. Res. 61, 103-138 (2003).
4. Saxena SK, Singh M, Pathak AK, Mathur A: Reply to 'Encephalitis outbreak finds Indian officials unprepared'. Nat. Med. 12, 269-270 (2006).
5. Mackenzie JS, Gubler DJ, Petersen LR: Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10, S98-S109 (2004).
6. McCormack JG, Allworth AM: Emerging viral infections in Australia. Med. J. Aust. 177, 45-49 (2002).
7. Bharati K, Vrati S: Japanese encephalitis: development of new candidate vaccines. Expert Rev. Anti Infect. Ther. 4, 313-324 (2006).
8. Lanciotti RS: Molecular amplification assays for the detection of flaviviruses. Adv. Virus Res. 61, 67-99 (2003).
9. Weaver SC: Host range, amplification and arboviral disease emergence. Arch. Virol. Suppl. 19, 33-44 (2005).
10. Weaver SC, Barrett AD: Transmission cycles, host range, evolution and emergence of arboviral disease. Nat. Rev. Microbiol. 2, 789-801 (2004).
11. Mathur A, Arora KL, Chaturvedi UC: Congenital infection of mice with Japanese encephalitis virus. Infect. Immun. 34, 26-29 (1981).
12. Kennedy PG: Neurological infection. Lancet Neurol. 3, 13 (2004).
13. Mathur A, Arora KL, Chaturvedi UC: Host defence mechanisms against Japanese encephalitis virus infection in mice. J. Gen. Virol. 64, 805-811 (1983).
14. Mathur A, Khanna N, Chaturvedi UC: Breakdown of blood-brain barrier by virus-induced cytokine during Japanese encephalitis virus infection. Int. J. Exp. Pathol. 73, 603-611 (1992).
15. Saxena SK, Mathur A, Srivastava RC: Inhibition of Japanese encephalitis virus infection by diethyldithiocarbamate is independent of its antioxidant potential. Antivir. Chem. Chemother. 14, 91-98 (2003).
16. Saxena SK, Mathur A, Srivastava RC: Induction of nitric oxide synthase during Japanese encephalitis virus infection: evidence of protective role. Arch. Biochem. Biophys. 391, 1-7 (2001).
17. Saxena SK, Singh A, Mathur A: Antiviral effect of nitric oxide during Japanese encephalitis virus infection. Int. J. Exp. Pathol. 81, 165-172 (2000).
18. Tandon A, Singh A, Atrishi E et al.: Alteration in plasma glucose levels in Japanese encephalitis patients. Int. J. Exp. Pathol. 83, 39-46 (2002).
19. Solomon T: Exotic and emerging vital encephalitides. Curr. Opin. Neurol. 16, 411-418 (2003).
20. Mathur A, Bharadwaj M, Kulshreshtha R et al.: Immunopathological study of spleen during Japanese encephalitis virus infection us mice. Br. J. Exp. Pathol. 69, 423-432 (1988).
21. Chung CC, Lee SS, Chen YS et al.: Acute flaccid paralysis as an unusual presenting symptom of Japanese encephalitis: a case report and of the literature. Infection 35, 30-32 (2007).
22. Myint KS, Gibbons RV, Perng GC, Solomon T: Unravelling the neuropathogenesis of Japanese encephalitis. Trans. R. Soc. Trop. Med. Hyg. 101, 955-956 (2007).
23. Maschke M, Kastrup O, Forsting M, Diener HC: Update on neuroimaging in infectious central nervous system disease. Curr. Opin. Neurol. 17, 475-480 (2004).
24. Abe T, Kojima K, Shoji H et al.: Japanese encephalitis. J. Magn. Reson. Imaging 8, 755-761 (1998).
25. Gould EA, Solomon T: Pathogenic flaviviruses. Lancet 371, 500-509 (2008).
26. Oya A, Kurane I: Japanese encephalitis for a reference to international travelers. J. Travel Med. 14, 259-268 (2007).
27. McGovern LM, Boyce TG, Fischer PR: Congenital infections associated with international travel during pregnancy. J. Travel. Med. 14, 117-128 (2007).
28. Awada A, Kojan S: Neurological disorders and travel. Int. J. Antimicrob. Agents 21, 189-192 (2003).
29. Mathur A, Rashmi K, Sharma S et al.: Rapid diagnosis of Japanese encephalitis by immunofluorescent examination of cerebrospinal fluid. Ind. J. Med. Res. 91, 1-4 (1990).
30. Leyssen P, De Clercq E, Neyts J: Perspectives for the treatment of infections with Flaviviridae. Clin. Microbiol. Rev. 13, 67-82 (2000).
31. Beasley DW, Lewthwaite P, Solomon T: Current use and development of vaccines for Japanese encephalitis. Expert Opin. Biol. Ther. 8, 95-106 (2008).
32. Schiøler KL, Samuel M, Wai KL: Vaccines for preventing Japanese encephalitis. Cochrane Database Syst. Rev. 3, CD004263 (2007).
33. Ray D, Shi PY: Recent advances in flavivirus antiviral drug discovery and vaccine development. Recent Patents Anti-infect. Drug Disc. 1, 45-55 (2006).
34. Keiser J, Maltese MF, Erlanger TE et al.: Effect of irrigated rice agriculture on Japanese encephalitis, including challenges and opportunities for integrated vector management. Acta Trop. 95, 40-57 (2005).